| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 259.74B | 249.53B | 229.86B | 236.24B | 228.59B | 220.45B |
| Gross Profit | 92.86B | 88.37B | 75.42B | 79.46B | 77.15B | 73.29B |
| EBITDA | 21.66B | 19.14B | 15.66B | 16.41B | 15.64B | 14.73B |
| Net Income | 9.40B | 8.13B | 6.36B | 7.24B | 7.01B | 7.05B |
Balance Sheet | ||||||
| Total Assets | 223.23B | 228.17B | 194.95B | 194.33B | 189.91B | 187.91B |
| Cash, Cash Equivalents and Short-Term Investments | 31.13B | 31.29B | 31.30B | 24.57B | 24.80B | 38.94B |
| Total Debt | 34.56B | 37.82B | 9.32B | 12.19B | 10.76B | 12.66B |
| Total Liabilities | 91.43B | 96.20B | 65.80B | 67.37B | 67.02B | 64.08B |
| Stockholders Equity | 131.41B | 131.81B | 128.84B | 126.62B | 122.55B | 123.18B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.98B | 5.28B | 3.50B | -588.00M | 13.17B |
| Operating Cash Flow | 0.00 | 3.94B | 14.43B | 10.69B | 5.71B | 17.16B |
| Investing Cash Flow | 0.00 | -18.02B | -449.00M | -7.65B | -7.71B | -6.08B |
| Financing Cash Flow | 0.00 | 13.97B | -7.41B | -3.50B | -12.30B | -309.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥138.49B | 15.15 | 7.75% | 3.63% | 17.43% | 248.12% | |
74 Outperform | ¥358.51B | 8.80 | ― | 1.35% | 15.92% | 52.76% | |
67 Neutral | ¥2.56B | 8.16 | ― | 1.92% | 11.96% | 30.75% | |
66 Neutral | ¥308.90B | 16.14 | 11.17% | 2.61% | 5.63% | 25.64% | |
64 Neutral | ¥485.49B | 16.61 | 4.18% | 2.57% | 1.26% | 14.65% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥267.26B | 24.71 | ― | 2.72% | 2.23% | 57.10% |
Autobacs Seven reported that in January 2026 its domestic same-store sales rose 8.1% year-on-year and total-store sales increased 9.1%, marking a solid improvement from the prior year. The company attributed the gains primarily to strong demand for tires, tire chains and batteries driven by a cold snap and snowfall, alongside robust performance in its car purchase and sales business, while the number of weekends and national holidays was unchanged from a year earlier, suggesting underlying operational strength rather than calendar effects.
The most recent analyst rating on (JP:9832) stock is a Buy with a Yen1822.00 price target. To see the full list of analyst forecasts on Autobacs Seven Co stock, see the JP:9832 Stock Forecast page.
Autobacs Seven reported strong consolidated results for the nine months ended 31 December 2025, with net sales rising 12.6% year on year to ¥211.96 billion, operating profit up 25.2% to ¥12.45 billion, and profit attributable to owners of parent increasing 14.1% to ¥8.72 billion, lifting basic earnings per share to ¥111.02. The company’s total assets expanded to ¥269.68 billion and net assets to ¥137.43 billion, although the equity ratio declined to 50.8%, and management kept its full-year forecast unchanged, targeting ¥276.0 billion in net sales and ¥8.2 billion in profit attributable to owners of parent, alongside maintaining an annual dividend forecast of ¥60 per share, signaling confidence in earnings stability and continued shareholder returns.
The most recent analyst rating on (JP:9832) stock is a Buy with a Yen1816.00 price target. To see the full list of analyst forecasts on Autobacs Seven Co stock, see the JP:9832 Stock Forecast page.
Autobacs Seven reported that in December 2025 its domestic same-store sales fell 4.4% year on year, while total-store sales declined 3.5%, reflecting weaker demand for seasonal winter items such as snow tires and chains despite an unchanged number of weekends and national holidays compared with a year earlier. Offsetting some of this softness, the company noted solid performance in higher-value service categories, particularly safety inspection and maintenance and car purchase and sales, underscoring an ongoing shift in its revenue mix toward services even as product sales in weather-sensitive categories remain volatile.
The most recent analyst rating on (JP:9832) stock is a Buy with a Yen1776.00 price target. To see the full list of analyst forecasts on Autobacs Seven Co stock, see the JP:9832 Stock Forecast page.